Aditxt, Inc. (NASDAQ:ADTX – Get Free Report) major shareholder Financial Lp Hrt sold 3,132,480 shares of Aditxt stock in a transaction that occurred on Tuesday, June 16th. The shares were sold at an average price of $0.01, for a total value of $31,324.80. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Major shareholders that own at least 10% of a company’s stock are required to disclose their sales and purchases with the SEC.
Financial Lp Hrt also recently made the following trade(s):
- On Friday, June 12th, Financial Lp Hrt purchased 4,252,767 shares of Aditxt stock. The stock was acquired at an average price of $0.02 per share, for a total transaction of $85,055.34.
- On Friday, June 5th, Financial Lp Hrt sold 735,462 shares of Aditxt stock. The shares were sold at an average price of $0.06, for a total transaction of $44,127.72.
- On Thursday, June 4th, Financial Lp Hrt purchased 843,622 shares of Aditxt stock. The shares were purchased at an average cost of $0.08 per share, with a total value of $67,489.76.
- On Friday, April 24th, Financial Lp Hrt sold 1,089 shares of Aditxt stock. The shares were sold at an average price of $7.56, for a total value of $8,232.84.
- On Thursday, April 23rd, Financial Lp Hrt sold 141 shares of Aditxt stock. The stock was sold at an average price of $7.83, for a total value of $1,104.03.
- On Tuesday, April 21st, Financial Lp Hrt bought 2,700 shares of Aditxt stock. The stock was purchased at an average price of $8.91 per share, with a total value of $24,057.00.
- On Wednesday, April 22nd, Financial Lp Hrt sold 443 shares of Aditxt stock. The stock was sold at an average price of $8.10, for a total value of $3,588.30.
Aditxt Trading Up 136.4%
Shares of Aditxt stock opened at $0.01 on Friday. Aditxt, Inc. has a 12 month low of $0.00 and a 12 month high of $53,451.08. The business’s fifty day simple moving average is $3.99 and its 200 day simple moving average is $125.99.
Wall Street Analyst Weigh In
A number of research firms have commented on ADTX. Weiss Ratings reissued a “sell (e+)” rating on shares of Aditxt in a report on Monday, April 20th. Wall Street Zen upgraded shares of Aditxt to a “sell” rating in a report on Saturday, May 23rd. One analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock presently has an average rating of “Sell”.
Get Our Latest Research Report on ADTX
Aditxt Company Profile
Aditxt, Inc is a clinical-stage biotechnology company focused on the development and commercialization of natural antimicrobial peptides and microbiome-based detection technologies. Leveraging proprietary peptide libraries, the company aims to provide novel solutions for infection prevention and control across healthcare, food safety, animal health and agricultural markets. Aditxt’s approach centers on harnessing peptides that can disrupt microbial cell membranes without promoting resistance, addressing a growing need for alternatives to traditional antibiotics and chemical disinfectants.
The company’s product offerings include contract-based microbial detection and identification services, designed to help hospitals, food processors and other regulated industries monitor contamination levels and validate hygiene protocols.
Featured Stories
- Five stocks we like better than Aditxt
- How to Invest in the Biggest European Defense Surge in Decades
- The Netflix-Lionsgate Rumor Exposed a Bigger Shift in Media M&A
- Credo Technologies Accelerates AI—Its Stock Price Will Follow
- Qualcomm Goes All-In: The $10B Bet to Crush NVIDIA
Receive News & Ratings for Aditxt Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aditxt and related companies with MarketBeat.com's FREE daily email newsletter.
